The Readout Loud

350 Afleveringen

1. 326: Crypto for CRISPR, a new RNAi startup, & a Nobel for AI

   Gepubliceerd: 10-10-2024
2. 325: Biden's health care AI czar, a new obesity company, and its dealmaking CEO

   Gepubliceerd: 3-10-2024
3. From Tradeoffs: Race to the Bottom

   Gepubliceerd: 28-9-2024
4. 324: Genentech's cancer pivot, Pfizer's sickle cell withdrawal, and a new schizophrenia drug

   Gepubliceerd: 26-9-2024
5. 323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates

   Gepubliceerd: 19-9-2024
6. 322: A new threat to Merck's blockbuster cancer treatment, Moderna's cutbacks, and obesity drugs for kids

   Gepubliceerd: 12-9-2024
7. 321: Summit's upcoming cancer results, Recursion's mixed data, and the next big obesity target

   Gepubliceerd: 5-9-2024
8. 320: Jim Wilson's next venture, a surprise startup shutdown, & Lilly's Zepbound strategy

   Gepubliceerd: 29-8-2024
9. From "Say More": What Happens When AI Decides Your Medical Coverage

   Gepubliceerd: 23-8-2024
10. 319: BioMarin's executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion's AI bona fides

    Gepubliceerd: 22-8-2024
11. 318: Drug pricing drops & psychedelics under fire

    Gepubliceerd: 15-8-2024
12. 317: VC struggles, drug pricing negotiations, & Novo's abrupt Wegovy decision

    Gepubliceerd: 8-8-2024
13. 316: The long journey to make malaria vaccines, and Sarepta's ties with patient advocates

    Gepubliceerd: 1-8-2024
14. 315: UnitedHealth's doctor empire, an FDA departure, and Viking's obesity moves

    Gepubliceerd: 25-7-2024
15. 314: JD Vance's biotech ties, Cassava resignations, and insulin shortages

    Gepubliceerd: 18-7-2024
16. 313: Biotech layoffs, founder-focused VC, & a big pharma exit

    Gepubliceerd: 11-7-2024
17. 312: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate

    Gepubliceerd: 27-6-2024
18. 311: Fauci's memoir, Alnylam's tenuous trial, and a mid-year review

    Gepubliceerd: 20-6-2024
19. 310: Duchenne gene therapy setback, Alzheimer's drug endorsement & why a STAT reporter buys weed (for journalism)

    Gepubliceerd: 13-6-2024
20. 309: Psychedelics at the FDA, ASCO recap, & MorphoSys update

    Gepubliceerd: 6-6-2024